Supplement

Appendix: Expenditures for Medicaid Patients Treated With Exenatide Compared With Other Diabetes Management Regimens

Published Online: September 27, 2012

 



 
Log in to access PDF
Issue: Expenditures for Medicaid Patients Treated With Exenatide Compared With Other Diabetes Management Regimens
ARTICLES
Expenditures for Medicaid Patients Treated With Exenatide Compared With Other Diabetes Management Regimens
Jennie H. Best, PhD; John A. Romley, PhD; Dana P. Goldman, PhD; Ryan M. Conrad, PhD; and Anne L. Peters, MD
Appendix: Expenditures for Medicaid Patients Treated With Exenatide Compared With Other Diabetes Management Regimens
AUTHOR INDEX
Participating Faculty: Expenditures for Medicaid Patients Treated With Exenatide Compared With Other Diabetes Management Regimens
Click for Full Issue
More on AJMC.COM
Health Reform Plans, Pricing Revealed in Calif.
Dr. Jeff Goldsmith Addresses the Unintended Consequences of ACOs
NOW AVAILABLE: AMCP Spring 2013 Conference Coverage
The Affordable Care Act: Implications for Clinical Practice and Research
Dr Richard Channick, MD, Discusses Clinical Trial in Pulmonary Hypertension
About Us | Contact Us | Advertise | Terms & Conditions | Press Room | Copyright HCPLive 2006-2013 | Intellisphere, LLC. All Rights Reserved.
Partner Websites: Pharmacy Times | Targeted Therapies | PainLive | HCPLive | ONCLive